Tracy Creed
Family · Valdosta, GANPI 1912157272
Payments from drug & device makers
Across 142 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$770
- Amgen$306
- UCB, Inc.$296
- Novartis$207
- Pfizer$192
- Johnson & Johnson$141
- plus $858 from 25 others
What the payments were for
- Food & beverage$2,72098%
- Education$492%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $770 |
| Amgen | 17 | $306 |
| UCB, Inc. | 18 | $296 |
| Novartis | 10 | $207 |
| Pfizer | 10 | $192 |
| Johnson & Johnson | 5 | $141 |
| Aurinia Pharma U.S., Inc. | 6 | $133 |
| Boehringer Ingelheim | 4 | $77 |
| GSK | 3 | $57 |
| Mallinckrodt Hospital Products Inc. | 2 | $45 |
| Radius Health, Inc. | 2 | $44 |
| Corcept Therapeutics | 2 | $43 |
| AstraZeneca | 2 | $41 |
| Ascendis Pharma Endocrinology Inc | 2 | $40 |
| Ascensia Diabetes Care US Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $31 |
| Tandem Diabetes Care, Inc. | 1 | $27 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Amryt Pharma Holdings Ltd | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $23 |
| Abbott | 1 | $22 |
| Sandoz | 1 | $21 |
| Tonix Medicines, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| IBSA Pharma Inc. | 1 | $20 |
| Chiesi USA, Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Mannkind Corporation | 1 | $15 |
| Medtronic | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$125
How this compares
$2,769 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 49 | $388,075 |
| Humira(Cf) PenAdalimumab | 38 | $281,167 |
| Enbrel MiniEtanercept | 27 | $213,086 |
| RinvoqUpadacitinib | 23 | $140,986 |
| BenlystaBelimumab | 26 | $133,962 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $87,201 |
| SimponiGolimumab | 11 | $77,930 |
| OrenciaAbatacept | 12 | $68,923 |
| Orencia ClickjectAbatacept | 12 | $67,168 |
| Actemra ActpenTocilizumab | 14 | $32,199 |
| Hydroxychloroquine Sulfate | 505 | $11,477 |
| Mycophenolate Mofetil | 161 | $10,896 |
| SavellaMilnacipran Hcl | 16 | $9,639 |
| Duloxetine Hcl | 433 | $7,096 |
| FarxigaDapagliflozin Propanediol | 11 | $6,637 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq, Savella | $770 | $150,62539 claims |
| GSKBenlysta | $57 | $133,96226 claims |
| Johnson & JohnsonSimponi | $141 | $77,93011 claims |
| E.r. Squibb & Sons, L.L.C.Orencia | $25 | $68,92312 claims |
| Amneal Pharmaceuticals LLCMycophenolate Mofetil, Levothyroxine Sodium | $16 | $11,552205 claims |
| AstraZenecaFarxiga | $41 | $6,63711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,258 family providers in Georgia.
Other family in Valdosta
- Shelby McNealValdosta$14K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.